Filing Flows › Comparisons › DVA vs SHC
Davita vs Sotera Health: DVA and SHC compared
Davita is the larger company: $3.6B of revenue in its latest quarter (Q3 2026) against $325M for Sotera Health (Q3 2026). Davita is growing faster (+5% against +4% a year earlier). Sotera Health is more profitable, with an operating margin of 25.8% against 14.0%.
Where the money goes: DVA and SHC
Davita (DVA) · Q3 2026
Davita, Q3 2026: revenue $3.6B (+5% year over year), operating margin 14.0%, net earnings $223M, operating cash flow $519M. The chart follows the revenue to costs, profit and cash.
Sotera Health (SHC) · Q3 2026
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
| Davita (DVA) | Sotera Health (SHC) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $3.6B | $325M |
| Revenue growth, Y/Y | +5% | +4% |
| Gross margin | — | 55.6% |
| Operating margin | 14.0% | 25.8% |
| Net earnings | $223M | $58.4M |
| Net margin | 6.2% | 18.0% |
| Operating cash flow | $519M | $111M |
| Free cash flow | $276M | $57.7M |
| Market value | $12.5B | $5.2B |
| P/E | 14.2× | 30.2× |
| Analysts’ mean target | $222.29 | $21.94 |
Where the revenue comes from
Davita
- U. S. Dialysis and Related Lab Services: $3.0B (85%)
- Other - Ancillary Services: $550M (15%)
Sotera Health
- Sterigenics: $209M (64%)
- Nelson Labs: $60.6M (19%)
- Nordion: $55.0M (17%)
Questions
Which is bigger, Davita or Sotera Health?
Davita is the larger company: $3.6B of revenue in its latest quarter (Q3 2026) against $325M for Sotera Health (Q3 2026).
Is Davita or Sotera Health growing faster?
Davita is growing faster (+5% against +4% a year earlier).
Which is more profitable, Davita or Sotera Health?
Sotera Health is more profitable, with an operating margin of 25.8% against 14.0%.
More: Davita earnings · how Davita makes money · Sotera Health earnings · how Sotera Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.